Vaccinex, Inc.

Home » Vaccinex, Inc.

IPO

Vaccinex, Inc.

We are a clinical-stage biotechnology company engaged in the discovery and development of targeted biotherapeutics to treat serious diseases and conditions with unmet medical needs, including cancer, neurodegenerative diseases, and autoimmune disorders.

Symbol

VCNX

Final Price
$12.00

Final Shares
3,333,000

Effective Date
August 9, 2018

Underwriters
Oppenheimer & Co., BTIG, Ladenburg Thalmann

To view the prospectus for Vaccinex, Inc. IPO, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253